Neuberger Berman Canada’s Quest Diagnostics DGX Stock Holding History

Neuberger Berman Canada’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	$1.13M	Sell	12,079 -1,766	-13%	-$187K	0.21%	127
2017 Q2	$1.54M	Sell	13,845 -4,607	-25%	-$487K	0.29%	75
2017 Q1	$1.81M	Buy	18,452 +7,967	+76%	+$759K	0.36%	54
2016 Q4	$964K	Buy	10,485 +2,801	+36%	+$241K	0.24%	111
2016 Q3	$650K	Sell	7,684 -1,861	-19%	-$156K	0.2%	160
2016 Q2	$777K	Sell	9,545 -3,082	-24%	-$235K	0.25%	142
2016 Q1	$902K	Sell	12,627 -798	-6%	-$53.5K	0.33%	98
2015 Q4	$955K	Sell	13,425 -4,760	-26%	-$320K	0.38%	85
2015 Q3	$1.12M	Sell	18,185 -5,364	-23%	-$375K	0.49%	98
2015 Q2	$1.71M	Buy	+23,549	New	+$1.74M	0.46%	46
2013 Q4	–	Sell	-29,450	Closed	-$1.82M	–	255
2013 Q3	$1.82M	Buy	29,450 +16,770	+132%	+$1M	0.54%	36
2013 Q2	$769K	Buy	+12,680	New	+$755K	0.15%	159

Other funds holding DGX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Neuberger Berman Canada's DGX Position: Q3 2017 in Review

Neuberger Berman Canada reduced its Quest Diagnostics (DGX) stake by 13% in Q3 2017, selling an estimated $187K and leaving 12,079 shares worth $1.13M. The position accounts for 0.21% of the portfolio, ranked #127.

Neuberger Berman Canada first reported a position in DGX in Q2 2013 and has held it in 12 quarters since. The position peaked at $1.82M in Q3 2013. 616 funds tracked by Wall St. Rank hold DGX as of Q3 2017.

Neuberger Berman Canada held 12,079 shares of Quest Diagnostics worth $1.13M as of Q3 2017.
Neuberger Berman Canada sold 1,766 Quest Diagnostics shares in Q3 2017, an estimated $187K.
Quest Diagnostics made up 0.21% of Neuberger Berman Canada's portfolio in Q3 2017, its #127 holding.
Neuberger Berman Canada first reported a position in Quest Diagnostics in Q2 2013 and has held it in 12 quarters since.
Neuberger Berman Canada's Quest Diagnostics position peaked at $1.82M in Q3 2013.
616 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2017.

Based on Neuberger Berman Canada's 13F filing for Q3 2017, filed 3 Nov 2017.